S&P 500   3,087.01 (-0.20%)
DOW   27,691.49 (+0.04%)
QQQ   200.96 (-0.13%)
CGC   20.30 (-5.41%)
BABA   186.71 (-0.24%)
GE   11.35 (-1.48%)
T   39.37 (-0.03%)
F   9.08 (+0.44%)
ACB   3.62 (-4.99%)
PRI   129.23 (-0.37%)
BAC   33.18 (-0.24%)
DIS   136.74 (-0.88%)
S&P 500   3,087.01 (-0.20%)
DOW   27,691.49 (+0.04%)
QQQ   200.96 (-0.13%)
CGC   20.30 (-5.41%)
BABA   186.71 (-0.24%)
GE   11.35 (-1.48%)
T   39.37 (-0.03%)
F   9.08 (+0.44%)
ACB   3.62 (-4.99%)
PRI   129.23 (-0.37%)
BAC   33.18 (-0.24%)
DIS   136.74 (-0.88%)
Log in

iShares Dow Jones US Medical Dev. Stock Price, Forecast & Analysis (BMV:IHI)

Add
Today's Range N/A
50-Day Range
$238.40
MA: $245.02
$251.35
52-Week Range N/A
Volume880 shs
Average Volume30 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
CUSIPN/A
CIKN/A
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableOptionable

Receive IHI News and Ratings via Email

Sign-up to receive the latest news and ratings for IHI and its competitors with MarketBeat's FREE daily newsletter.


iShares Dow Jones US Medical Dev. (BMV:IHI) Frequently Asked Questions

What is iShares Dow Jones US Medical Dev.'s stock symbol?

iShares Dow Jones US Medical Dev. trades on the BMV under the ticker symbol "IHI."

How often does iShares Dow Jones US Medical Dev. pay dividends? What is the dividend yield for iShares Dow Jones US Medical Dev.?

iShares Dow Jones US Medical Dev. announced a -- dividend on Tuesday, September 24th. Shareholders of record on Wednesday, September 25th will be given a dividend of $0.1886 per share on Monday, September 30th. This represents a yield of 0.3%. The ex-dividend date is Tuesday, September 24th. View iShares Dow Jones US Medical Dev.'s Dividend History.

Has iShares Dow Jones US Medical Dev. been receiving favorable news coverage?

Press coverage about IHI stock has been trending very negative recently, InfoTrie Sentiment reports. The research firm scores the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. iShares Dow Jones US Medical Dev. earned a news impact score of -3.2 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the next few days. View News Stories for iShares Dow Jones US Medical Dev..

What other stocks do shareholders of iShares Dow Jones US Medical Dev. own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Dow Jones US Medical Dev. investors own include Merck & Co., Inc. (MRK), ARC Resources (ARX), Canadian Natural Resources (CNQ), Bmo Covered Call Utils Etf (ZWU), Adobe (ADBE), Gilead Sciences (GILD), iShares 20+ Year Treasury Bond ETF (TLT), salesforce.com (CRM), Shopify (SHOP) and Visa (V).

How do I buy shares of iShares Dow Jones US Medical Dev.?

Shares of IHI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.


MarketBeat Community Rating for iShares Dow Jones US Medical Dev. (BMV IHI)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  32 (Vote Outperform)
Underperform Votes:  32 (Vote Underperform)
Total Votes:  64
MarketBeat's community ratings are surveys of what our community members think about iShares Dow Jones US Medical Dev. and other stocks. Vote "Outperform" if you believe IHI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IHI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/11/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel